Makers of Generics Being Paid to Drop Patent Challenges

Subscribe (Free) to
Daily or Weekly Newsletters

Post a Job

Featured Jobs

Compliance Officer

New York City District Council of Carpenters Benefit Funds
(New York NY)

Senior Plan Administrator

Retirement Planners and Administrators (RPA)
(Remote)

Retirement Account Manager

Fringe Benefit Group
(Remote / Austin TX)

TPA Retirement Plan Consultant

EPIC RPS (TPA/DPS)
(Remote)

Defined Contributions Compliance Consultant

Loren D. Stark Company (LDSCO)
(Remote)

Retirement Plan Consultant

Great Lakes Pension Associates, Inc.
(Remote)

Senior Specialist 401k Recordkeeping

T Bank N.A.
(Dallas TX)

Combo Plan Administrator

Pollard & Associates
(Remote)

Retirement Plan Administrator

Retirement Solutions Specialists
(Remote / Jacksonville FL / Hybrid)

Defined Contribution Account Manager

Nova 401(k) Associates
(Remote)

RP-Client Service Associate

Greenline Wealth Management
(FL / Hybrid)

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Makers of Generics Being Paid to Drop Patent Challenges
The Washington Post; subscription may be required

Apr. 25, 2006

Excerpt: Brand-name drug companies have resumed the practice of slowing the sale of cheaper generic competitors by cutting deals that result in paying millions of dollars to makers of generic drugs while consumers continue to pay brand-name prices.

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title).

An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above).